643 related articles for article (PubMed ID: 7995771)
1. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
[TBL] [Abstract][Full Text] [Related]
2. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
3. Comparision of four different dose specification methods for high-dose-rate intracavitary radiation for treatment of cervical cancer.
Mai J; Erickson B; Rownd J; Gillin M
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1131-41. PubMed ID: 11704338
[TBL] [Abstract][Full Text] [Related]
4. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
Davidson MT; Yuen J; D'Souza DP; Batchelar DL
Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
[TBL] [Abstract][Full Text] [Related]
5. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
6. Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study.
Serban M; Kirisits C; de Leeuw A; Pötter R; Jürgenliemk-Schulz I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Langeland Marthinsen AB; Whitney D; Lindegaard J; Tanderup K;
Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1052-1062. PubMed ID: 32007365
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience.
Tan LT; Coles CE; Hart C; Tait E
Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):175-82. PubMed ID: 19101130
[TBL] [Abstract][Full Text] [Related]
8. Comparison of traditional low-dose-rate to optimized and nonoptimized high-dose-rate tandem and ovoid dosimetry.
Decker WE; Erickson B; Albano K; Gillin M
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):561-7. PubMed ID: 11380246
[TBL] [Abstract][Full Text] [Related]
9. 3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer.
Dewitt KD; Hsu IC; Speight J; Weinberg VK; Lessard E; Pouliot J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1270-4. PubMed ID: 16253782
[TBL] [Abstract][Full Text] [Related]
10. Is simulation necessary for each high-dose-rate tandem and ovoid insertion in carcinoma of the cervix?
Jones ND; Rankin J; Gaffney DK
Brachytherapy; 2004; 3(3):120-4. PubMed ID: 15533802
[TBL] [Abstract][Full Text] [Related]
11. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
12. Use of the rectal retractor to reduce the rectal dose in high dose rate intracavitary brachytherapy for a carcinoma of the uterine cervix.
Lee KC; Kim TH; Choi JH; Choi MS; Kim CY; Kim JY
Yonsei Med J; 2004 Feb; 45(1):113-22. PubMed ID: 15004877
[TBL] [Abstract][Full Text] [Related]
13. Retrospective dosimetric comparison of low-dose-rate and pulsed-dose-rate intracavitary brachytherapy using a tandem and mini-ovoids.
Mourtada F; Gifford KA; Berner PA; Horton JL; Price MJ; Lawyer AA; Eifel PJ
Med Dosim; 2007; 32(3):181-7. PubMed ID: 17707197
[TBL] [Abstract][Full Text] [Related]
14. [Optimization of dose distribution in combined irradiation of uterine cervix cancer with gamma-ray cesium-137 and X-9 MeV].
Lewocki M
Ann Acad Med Stetin; 1996; 42():199-222. PubMed ID: 9199121
[TBL] [Abstract][Full Text] [Related]
15. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
[TBL] [Abstract][Full Text] [Related]
16. High dose rate (HDR) brachytherapy technique: for carcinoma of uterine cervix using Nucletron applicators.
Nair MT; Cheng MC; Barker A; Rouse BS
Med Dosim; 1995; 20(3):201-7. PubMed ID: 7576095
[TBL] [Abstract][Full Text] [Related]
17. Influence of different Fletcher-Suit applicator geometries on sagittal dose distribution.
Palvolgyi J
Phys Med; 2010 Jan; 26(1):49-54. PubMed ID: 19386528
[TBL] [Abstract][Full Text] [Related]
18. Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading.
Brooks S; Bownes P; Lowe G; Bryant L; Hoskin PJ
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):934-9. PubMed ID: 16199322
[TBL] [Abstract][Full Text] [Related]
19. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
[TBL] [Abstract][Full Text] [Related]
20. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
